Endotension after endovascular treatment of abdominal aortic aneurysm: Percutaneous treatment  by Cerna, Marie et al.
Endotension after endovascular treatment of
abdominal aortic aneurysm: Percutaneous
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Endotension is one of the possible specific late complications of endovascular treatment of abdominal aortic aneurysm
(AAA). We describe the treatment of endotension in a small group of 3 patients (all men, aged 58, 70, and 70-years-old)
by translumbar puncture of the aneurysm sac and aspiration of its content. It was transudate and its culture was negative.
Sac size reduced after aspiration in all patients and no subsequent enlargement was seen. Percutaneous translumbar
puncture of the aneurysm sac with aspiration of sac content could be an easy and effective method of treatment in
endotension. But a larger group of patients and long-term follow-up are needed. (J Vasc Surg 2009;50:648-51.)Endovascular treatment of abdominal aortic aneurysm
(AAA) is indicated in patients with high risk of operation or
contraindication to surgery.1,2 Patients after endovascular
aneurysm repair (EVAR) are regularly followed-up by im-
aging methods to get information about aneurysm size,
endoleaks, and stent graft itself to detect possible compli-
cations and treatment failure in time.3 Endotension (per-
sisting or recreated increased pressure in growing aneurysm
sac size without evidence of endoleak) is one of the possible
specific late complications of endovascular treatment of
AAA.
The aim of this paper is to describe the treatment
possibility of endotension after stent graft implantation for
AAA by percutaneous translumbar puncture of aneurysm
sac with aspiration of sac content.
CASE REPORT
From April 1996 to March 2008, 214 patients with AAA were
endovascularly treated by Ella stent graft (Ella-CS, Hradec
Králové, Czech Republic) at our department.4 All patients after
stent graft implantation were followed-up by computed tomogra-
phy (CT) angiography scan with delay phase and x-ray every year.
In follow-up, aneurysm sac size increased in 14 patients. In 3
patients with increased aneurysm sac, stent graft was intact without
disintegration of skeleton and endoleak was not found. This was
confirmed in addition by ultrasound scan and angiography with
catheterization of superior mesenteric artery (SMA) and internal
iliac arteries. In these 3 patients, endotension was diagnosed.
The Ella stent graft is a fully supported self-expanding endo-
prosthesis of a stainless steel wire framework covered with woven
0.25 mm thick macro porous polyester (Fig 1).
From the Department of Radiology,a and the Department of Vascular
Surgery,b University Hospital.
Competition of interest: none.
Reprint requests: Martin Köcher, MD, PhD, Department of Radiology,
University Hospital, I. P. Pavlova 6, 775 20 Olomouc, Czech Republic
(e-mail: martin.kocher@seznam.cz).
0741-5214/$36.00
Copyright © 2009 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2009.04.044
648Patient 1. First, a 58-year-old male’s bifurcated stent graft
was implanted in 1999 for an aneurysm with a sac size of 55  55
mm. In yearly follow-up CT scans during the 5 years after implan-
tation, the sac size was stable without any type of endoleak. Sac
Fig 1. Ella stent graft.increase occurred rapidly after 6 years after stent graft implanta-
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stent graft was found. Migration was managed by proximal cuff.
After this secondary intervention, additional increase of sac size
continued to 90 100 mm after another year without evidence of
stent graft migration, damage, or endoleak on imaging methods.
Translumbar puncture of the aneurysm sac with aspiration of the
sac content was indicated and performed under fluoroscopic con-
trol with antibiotics cover and strict sterile conditions. We used
Chiba needle (William Cook Europe, Bjaeverskov, Denmark) for
puncture. The needle was directed to the level of the maximum
diameter of the aneurysm sac size and so that the puncture could be
performed safely. We administered small amount of contrast me-
dium to confirm the position of the needle. Puncture was per-
formed by one pass. Transudate was aspirated as much as possible.
We aspirated 180 mL pure bloodless yellowish liquid. Culture of
aspirated liquid was negative. A CT scan was performed immedi-
ately after puncture and yearly thereafter. Afterwards, the puncture
sac size decreased to 85  90 mm. To date, the patient is 2 years
after aspiration and the sac is still stationary.
Patient 2. The second patient was a 70-year-old male with
AAA 60  67 mm bifurcated stent graft which was implanted in
2001. Two years after the operation, the aneurysm sac size in-
creased to 82  90 mm without evidence of stent graft migration
or disintegration and without endoleak. We performed the same
procedure, ie, aneurysm puncture with aspiration by the same tech-
nique. We aspirated 140 mL of transudate. Aspirated sac content had
the same character - transudate and culture was negative. Immediately
after aspiration, the sac size decreased to 59 68 mm and continues
to be stable. To date, the patient is 5 years after aspiration and the sac
is still stationary.
Patient 3. The third patient was a 70-year-old male who was
treated by bifurcated stent graft for AAA with sac size 65 78 mm
in 2001. Sac size was stable during the first 4 years after implanta-
tion on follow-up CT scan. Five years after endovascular treatment,
the sac size steadily increased to 88  101 mm without evident
cause on CT scan, x-ray, ultrasound scan, and angiography. In this
patient, translumbar puncture with aspiration of 140 mL of tran-
sudate with negative culture was also performed. After aspiration,
the sac decreased to 60  68 mm and has continued to be
stationary for 2 years (Fig 2).
In all these patients, we were able to stop further aneurysm sac
increase. We did not measure intra-aneurysmal pressure during the
sac puncture because we did not keep a device for measurement of
intra-aneurysmal pressure at disposal. Sac puncture was performed
just in one site as the pressure could be different in different places
in the aneurysm sac and pressure measurement would not change
management of these patients with endotension.
DISCUSSION
Patients after EVAR are regularly followed-up by im-
aging methods. In follow-up of aneurysm sac size after
stent graft implantation, sac size decrease or complete sac
collapse is unequivocal evidence of successful endovascular
treatment of AAA and it indirectly represents decreased
pressure inside excluded aneurysm sac from circulation by
stent graft.5 On the other side, the sac size increase is
considered to be treatment failure. Sac increase is usually
linked to endoleak.If endoleak is not diagnosed in increasing sac and stent
graft is without migration or disintegration, we speak about
endotension (endoleak type V).6,7 Incidence of endoten-
sion is 1.5 - 5%.8,9 In our group of patients treated by Ella
stent graft, incidence was similar 1.4%. Etiology of endo-
tension is still unclear. It is supposed to be due to the
presence of unrecognized endoleak, which is under resolu-
tion of imaging methods or transmission of pressure
through the thrombus or stent graft or increasing perme-
ability of covering material of stent graft with progressive
accumulation of transudate in the aneurysm sac. This in-
creased permeability is described in polytetrafluoroethylene
stent grafts and it inhibits organization of thrombus in
aneurysm sac.10-14 In endotension, increased fibrinolysis
inside the aneurysm sac was also found.15,16 Cause of
insufficient organization of thrombus can also be excessive
anticoagulation treatment and it can be managed by cor-
rection of coagulation parameters and subsequent moni-
toring.17
Management of endotension is still controversial. Re-
garding the fact that an increased aneurysm sac is consid-
ered to be endovascular treatment failure and is connected
with a high risk of rupture, patients are usually treated.
Endotension is treated by surgical conversion or endovas-
cularly. Endovascular treatment includes endovascular con-
version of polytetrafluoroethylene stent graft to polyester
stent graft12 or implantation of proximal and distal cuff for
reinforcement of stent graft.11 Laparoscopic fenestration of
the aneurysm sac with removal of all thrombotic material
was also reported.15,16 On the other side, some authors
recommend to follow-up patients if the patients with en-
dotension are not symptomatic, because they suppose
eventual rupture will not be dramatic and fatal.18 Never-
theless, increasing aneurysm sac size can lead to enlarge-
ment of landing zones, especially in proximal neck, and it
can lead to migration or disintegration of stent graft and to
type I or III of endoleak and subsequently to fatal rupture.6
We believe that patients with increasing aneurysm sac
size without evidence of endoleak (endotension) should be
treated due to possible dilatation of proximal neck and
development of type I or III endoleak with high risk of
rupture. In our patients, we successfully indicated puncture
of the aneurysm sac with aspiration of its content – transu-
date and stopped growing of aneurysm sac.
Our treatment is based on the presumption that endo-
tension arises because of the increased fibrinolysis inside
excluded aneurysmal sac,15,19 thereby leading to liquefac-
tion of the sac content. This hyperfibrinolysis leads to an
increase in protein concentration (fibrin degradation prod-
ucts [FDP]) and high oncotic pressure and this contributes
to an accumulation of fluid inside the sac by ultrafiltration
of plasma through the stent graft covering, which behaves
as a semipermeable membrane. By this process, the aneu-
rysmal sac enlarges. During transudation, the oncotic pres-
sure inside the aneurysmal sac gradually decreases and
becomes equal to oncotic blood pressure. If we perform
puncture of the aneurysmal sac, when oncotic pressure
inside the sac becomes almost equal to the blood oncotic
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September 2009650 Cerna et alFig 2. A 70-year-old man was indicated for treatment of abdominal aortic aneurysm (AAA) by bifurcated Ella stent
graft in November 2001. Original size of aneurysm was 65  78 mm. Five years after treatment endotension was
diagnosed and the patient was indicated for percutaneous translumbar puncture of the aneurysm sac with aspiration of
its content. A, Follow-up computed tomography (CT) scan 4 years after treatment showing stable size of aneurysm sac
64  79 mm. B, Follow-up CT scan 5 years after treatment with sac enlargement to 88  101 mm, it means increase
in size more then 20 mm per year. C, D, Percutaneous translumbar puncture of sac under fluoroscopy in two
projections. Approximately 140 mL of transudate was aspirated. E, Follow-up CT scan 6 years after stent graft
implantation and 1 year after sac puncture. Sac enlargement was stopped and aneurysm sac is decreased to 59 68 mm.
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not occur again. If the sac puncture is done when the
oncotic pressure inside the sac is still relatively high, then
transudation filling occurs again. However, with regard to
lesser amounts of rest sac content with high oncotic pres-
sure in comparison with the condition before puncture, the
amount of transudate after refilling of the aneurysmal sac
will be lesser, because the gradual equalization of pressures
on both sides of the semipermeable membrane will be
reached earlier. At this point, a repeated puncture should be
definitive.
Percutaneous translumbar puncture of the aneurysm
sac with aspiration of the sac content could be an easy and
effective method of treatment in endotension. But a larger
group of patients and long-term follow-up are needed.
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